ProtecT and CAP trial recruitment phases and endpoint assessment... | Download Scientific Diagram
High dose vitamin C 'ineffective' in treating Covid-19, but statin beneficial | NIHR
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial - The Lancet Infectious Diseases
The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM - Emergency Medicine Blog
REMAP-CAP – The Bottom Line
COVID study wins Trial of the Year award - Medicine, Nursing and Health Sciences
ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial
Media — REMAP-CAP Trial
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
March: Prostate cap trial | News and features | University of Bristol
CAP - Trial Practice, Second Edition (9780769855332). Authors: Michael Martin, Paul Radvany, Lawrence Dubin, Thomas F. Guernsey. Carolina Academic Press
The CAP-IT Trial: Amoxicillin Dose and Duration in Children with Community-Acquired Pneumonia - REBEL EM - Emergency Medicine Blog
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study
CAP trial design. *Further n = 1451 excluded due to prostate cancer... | Download Scientific Diagram
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP- COVID) - Sunnybrook Research Institute
REMAP-CAP Trial
Celebrating REMAP – CAPs success on International Clinical Trials Day – ACTA – Australian Clinical Trials Alliance
REMAP-CAP
Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking Clinical Trials
REMAP-CAP – The Bottom Line
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial - The Lancet Oncology